GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Takeda Pharmaceutical Co Ltd (WBO:TKD) » Definitions » Credit Losses Provision

Takeda Pharmaceutical Co (WBO:TKD) Credit Losses Provision


View and export this data going back to 2021. Start your Free Trial

What is Takeda Pharmaceutical Co Credit Losses Provision?

Credit Losses Provision only applies to banks.


Takeda Pharmaceutical Co (WBO:TKD) Business Description

Address
1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, JPN, 103-8668
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4 trillion in fiscal 2022. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the U.S., 20% from Japan, 20% from Europe and Canada.